NasdaqCM - Delayed Quote USD

Cerevel Therapeutics Holdings, Inc. (CERE)

41.99 -0.11 (-0.26%)
At close: April 23 at 4:00 PM EDT
41.99 0.00 (0.00%)
After hours: April 23 at 4:20 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
447,265.00
447,265.00
367,848.00
220,098.00
149,116.00
Operating Income
-447,265.00
-447,265.00
-367,848.00
-220,098.00
-149,116.00
Net Non Operating Interest Income Expense
33,298.00
33,298.00
9,619.00
157.00
224.00
Other Income Expense
-18,372.00
-18,372.00
6,878.00
-5,393.00
-3,274.00
Pretax Income
-432,339.00
-432,339.00
-351,351.00
-225,334.00
-152,166.00
Tax Provision
503.00
503.00
160.00
--
-24.00
Net Income Common Stockholders
-432,842.00
-432,842.00
-351,511.00
-225,334.00
-152,142.00
Diluted NI Available to Com Stockholders
-432,842.00
-432,842.00
-351,511.00
-225,334.00
-152,142.00
Basic EPS
-2.67
--
-2.32
-1.65
-2.01
Diluted EPS
-2.67
--
-2.32
-1.65
-2.01
Basic Average Shares
162,056.41
--
151,265.64
136,576.54
73,643.00
Diluted Average Shares
162,056.41
--
151,265.64
136,576.54
73,643.00
Total Operating Income as Reported
-447,265.00
-447,265.00
-367,848.00
-220,098.00
-149,116.00
Total Expenses
447,265.00
447,265.00
367,848.00
220,098.00
149,116.00
Net Income from Continuing & Discontinued Operation
-432,842.00
-432,842.00
-351,511.00
-225,334.00
-152,142.00
Normalized Income
-432,842.00
-432,842.00
-351,511.00
-221,453.00
-148,872.00
Interest Income
43,865.00
43,865.00
13,537.00
157.00
224.00
Interest Expense
10,567.00
10,567.00
3,918.00
--
--
Net Interest Income
33,298.00
33,298.00
9,619.00
157.00
224.00
EBIT
-421,772.00
-421,772.00
-347,433.00
-225,334.00
-149,116.00
EBITDA
-416,145.00
-416,145.00
-342,530.00
-222,603.00
-148,719.00
Reconciled Depreciation
5,627.00
5,627.00
4,903.00
2,731.00
397.00
Net Income from Continuing Operation Net Minority Interest
-432,842.00
-432,842.00
-351,511.00
-225,334.00
-152,142.00
Total Unusual Items Excluding Goodwill
--
--
6,876.00
-3,881.00
-3,270.00
Total Unusual Items
--
--
6,876.00
-3,881.00
-3,270.00
Normalized EBITDA
-416,145.00
-416,145.00
-342,530.00
-218,722.00
-145,449.00
Tax Rate for Calcs
0.00
0.00
0.00
--
--
12/31/2020 - 7/30/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SAGE Sage Therapeutics, Inc.
12.95
+0.47%
 
CGEM Cullinan Therapeutics, Inc.
16.67
+6.65%
 
DNLI Denali Therapeutics Inc.
16.11
+0.75%
 
BCYC Bicycle Therapeutics plc
22.68
+0.49%
 
EWTX Edgewise Therapeutics, Inc.
15.65
+3.78%
 
IMVT Immunovant, Inc.
28.61
-0.45%
 
CYTK Cytokinetics, Incorporated
65.57
-1.09%
 
DAWN Day One Biopharmaceuticals, Inc.
16.64
+8.19%
 
IGMS IGM Biosciences, Inc.
7.70
+14.07%
 
CRNX Crinetics Pharmaceuticals, Inc.
44.22
+1.80%